Antioxidant effect of frankincense extract in the brain cortex of diabetic rats

Antioxidant effect of frankincense extract in the brain cortex of diabetic rats Journal of the Association of Arab Universities for Basic and Applied Sciences (2016) xxx, xxx–xxx University of Bahrain[.]

Journal of the Association of Arab Universities for Basic and Applied Sciences (2016) xxx, xxx–xxx University of Bahrain Journal of the Association of Arab Universities for Basic and Applied Sciences www.elsevier.com/locate/jaaubas www.sciencedirect.com Antioxidant effect of frankincense extract in the brain cortex of diabetic rats Anwar Masoud a,*, Mohammad Al-Ghazali b, Fatima Al-Futini c, Anisah Al-Mansori c, Abdulalim Al-Subahi d, Abdulrahman Farhan d, Majdaldeen Al-Sharafi d, Reham Al-absi d, Sali Al-Matari d a Biochemical Technology Program, Box 87246, Thamar, Yemen b Department of Pharmacy, Faculty c Department of Biology, Faculty of d Department of Pharmacy, Faculty Department of Chemistry, Faculty of Applied Science, Thamar University, P.O of Medicine and Health Sciences, Thamar University, P.O Box 87246, Thamar, Yemen Science, Sana’a University, Sanaa, Yemen of Medical Sciences, Al-Nasser University, Sanaa, Yemen Received April 2016; revised 19 July 2016; accepted October 2016 KEYWORDS Alloxan; Diabetes mellitus; Frankincense; Thiols Abstract The number of diabetes mellitus (DM) patients is one of the major concerns worldwide As one of the main mechanisms of DM pathology is the involvement of oxidative stress, here we investigate the antioxidant capacities of frankincense (FRN) to treat or reduce the DM complications in the brain cortices of DM rats Animals were segregated into four groups, the control group, FRN group given a dose of 500 mg of FRN/kg for weeks, DM group given a single dose of 150/kg i.p of alloxan to induce diabetes and DM + FRN group given a single dose of 150/kg i.p to induce DM then followed by FRN 500 mg/kg for weeks The animals were sacrificed; their cerebral cortices were removed and used for biochemical and histopathological analyses Alloxan treatment in the DM group showed significant reductions in catalase (CAT) activity and other non-enzymatic antioxidants i.e thiol groups, concomitant with decreases in the levels of protein and albumin and increasing the level of uric acid However, FRN administration to DM animals in DM + FRN group showed significant recovery of antioxidants, the thiol contents (total thiols, protein thiols and glutathione) of DM + FRN group have been increased as compared with DM animals (p < 0.05) A recovery of CAT activity (p < 0.05) to almost the levels of control rats with the recovery in protein and albumin levels (p < 0.05) have been observed when FRN was administered The uric acid level increased in DM group, came back to the levels of control after administration of FRN (p < 0.05) We also observed that FRN reduces the histopathological damage caused by alloxan in DM + FRN group It is concluded that FRN shows a beneficial effects that can reduce the oxidative damage caused by alloxan induced DM in the cortex of rats Ó 2016 University of Bahrain Publishing services by Elsevier B.V This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) Abbreviations: CAT, catalase; DM, diabetes mellitus; FRN, frankincense; GSH, reduced glutathione; P-SH, Protein thiols; T-SH, total thiols * Corresponding author E-mail address: angaz76@gmail.com (A Masoud) Peer review under responsibility of University of Bahrain http://dx.doi.org/10.1016/j.jaubas.2016.10.003 1815-3852 Ó 2016 University of Bahrain Publishing services by Elsevier B.V This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) Please cite this article in press as: Masoud, A et al., Antioxidant effect of frankincense extract in the brain cortex of diabetic rats Journal of the Association of Arab Universities for Basic and Applied Sciences (2016), http://dx.doi.org/10.1016/j.jaubas.2016.10.003 Introduction The increasing patient’s number of diabetes mellitus (DM), expected to be 552 million by 2030, had lead the researchers to evaluate the capacity of natural products to either reduce or cure the complications of the disease (Whiting et al., 2011) DM has been shown to be a risk factor in the brains, causing cognitive impairments and dementia because the brain is the main glucose consumers with a 60% use of the total body’s glucose (Biessels et al., 2006; Exalto et al., 2012; Gorelick et al., 2011; Wasserman, 2009) One of the main features of DM is high glucose level, which advances to glycation end-products and will subsequently produce reactive oxygen species (ROS) which will result in cell damage and apoptosis (Brownlee, 2005) Two types of DM are known with at least 80% of cases having type II DM, also called non-insulin dependent DM, which can be induced in the animal models by injection of chemical compounds that have similarities with glucose in the body, such as alloxan yielding the main characteristics of DM include body weight loss, hyperglycemia, polyuria and dysregulation of insulin levels (King, 2012) Because of the lower side effects of the natural products, many medicinal plants have been used to cure different diseases Frankincense (FRN) is one of those plants which is an aromatic resin obtained from species of the Burseraceae family Boswellia sacra has been reported to possess a variety of pharmacological effects including anti-hyperglycemia effect, antioxidant effects, and anti-inflammatory effects (Akihisa et al., 2006; Banno et al., 2006; Gupta et al., 1998; Mothana, 2011; Mothana et al., 2007; Masoud et al., 2014) FRN extract has also been reported to possess antidiabetic action in streptozotocin- and alloxan-induced DM (Azemi et al., 2012; Kavitha et al., 2007; Masoud et al., 2014) The present study has been designed to study the possible antioxidant effects of FRN on rat’s brain cortices following DM development Materials and methods 2.1 Preparation of the FRN extract The freshly obtained plant from Hadramout Governorate, Yemen was grinded, suspended in ethanol (96%), shacked for h and the extract was prepared as described previously (Masoud et al., 2014; Chevrier et al., 2005) The selected dose of 500 mg/kg was given orally as it is reported as a safe dose (Devi et al., 2012) 2.2 DM Induction DM rats were given a single dose (150 mg/kg interaperitoneally) of freshly prepared alloxan monohydrate (SigmaAldrich, USA) dissolved in normal saline (0.9% w/v NaCl) to induce DM The levels of blood glucose were estimated in blood sample collected by tail tipping method using AccuChek Glucometer (China) Animals of glucose levels greater than 250 g/dl were selected for the study A Masoud et al domly into four groups having 6–8 animals The study was conducted for weeks and followed the guidance of animal care and use, Sana’a University The doses were given as follows: Control Group: These animals were given DMSO solution (n = 6) DM group: These animals injected with a single dose of 150/ kg interaperitoneally of alloxan to induce diabetes (n = 8) FRN group: Animals of this group received ethanolic extract of FRN (500 mg/kg) dissolved in DMSO solution for weeks (n = 6) DM + FRN group: Following DM induction by a single dose of 150/kg interaperitoneally of alloxan, the animals were dosed ethanolic extract of FRN (500 mg/kg) dissolved in DMSO solution for weeks (n = 8) 2.4 Sample preparation and isolation At the end of the study (5 weeks of FRN administration) animals were sacrificed by cervical dislocation, their brains were removed and the cortices were dissected and homogenized in phosphate buffered saline (pH 7.4) Part of the homogenates were centrifuged (3000g for 10 min) and the supernatants and rest of the homogenates were used for biochemical assays, also some cortices of each group were used for histopathological studies 2.5 Biochemical analyses 2.5.1 Total thiols The total thiol (T-SH) was spectrophotometrically quantified in the cerebral cortex homogenate according to the method of Ellman (1959) and as modified by Sedlak and Lindsay (1968) Tris–HCl (0.2 M) and EDTA (0.02 M, pH 8.2), homogenate and 0.01 M DTNB (in methanol) were incubated for 15 at room temperature then followed by centrifugation at 1200g for The absorbance was read at 412 nm and the results were expressed as nmoles of T-SH/mg protein using molar extension coefficient of DTNB (13,600 cm M 1) 2.5.2 Glutathione contents Glutathione (GSH) contents were measured in the cerebral cortex homogenate according to the method of Ellman (1959) Sulphosalicylic acid (4% w/v) was used to precipitate proteins, followed by centrifugation at 1200g for 0.1 mM DTNB in 0.1 M phosphate buffer (pH 8.0) was added to the supernatant and the absorbance was read at 412 nm after Results were expressed as nmoles of GSH/mg protein using molar extension coefficient of DTNB (13,600 cm M 1) 2.5.3 Protein thiols Protein thiols (P-SH) were measured by subtracting the GSH from T-SH and the results were expressed as nmoles of P-SH/mg protein using molar extension coefficient of DTNB (13,600 cm M 1) 2.3 Animals and treatments 2.5.4 Catalase (CAT) activity Female Albino rats were obtained and housed in the animal house unit, Sana’a University, Yemen They were divided ran- The activity of CAT was measured in the supernatant as described by Luck (1971) The absorbance of a reaction Please cite this article in press as: Masoud, A et al., Antioxidant effect of frankincense extract in the brain cortex of diabetic rats Journal of the Association of Arab Universities for Basic and Applied Sciences (2016), http://dx.doi.org/10.1016/j.jaubas.2016.10.003 Frankincense and diabetic brain mixture (supernatant and 12.5 mM H2O2 in 0.067 M phosphate buffer (pH 7.0) was followed at 240 nm for Results were expressed as lmoles of H2O2 decomposed/min/ mg protein using molar extinction coefficient of H2O2 (71 M cm 1) 2.5.5 Protein, albumin and uric acid assays The biochemical tests include assays of total protein, albumin, and uric acid (UA) were estimated following the instructions of commercial kits provided by Spinreact, Spain Table Thiol contents in the brain cortex of control, FRN, DM, DM + FRN rats (nmoles/mg protein) Group/Test GSH P-SH T-SH Control FRN DM DM + FRN 5.77 ± 0.80a 5.41 ± 0.06a 1.92 ± 0.16b 4.37 ± 0.16c 21.65 ± 2.34a 23.40 ± 2.98a 16.14 ± 1.87b 19.86 ± 1.38c 27.43 ± 3.14a 28.82 ± 3.05a 18.06 ± 2.04b 24.24 ± 1.54c Results are expressed as mean ± S.D.; n = in each group Superscript alphabets (a, b and c) are significantly different from their corresponding group, p < 0.05 2.5.6 Histopathological studies Histopathological studies were carried out by performing routine hematoxylin and eosin staining to evaluate the morphological and structural changes in the brain cortices and the slides were examined under light microscope 2.5.7 Statistical analysis Data were expressed as mean ± S.D and were analyzed by one way ANOVA followed by Student–Newman–Keuls post hoc test Differences between groups were considered significant when P < 0.05 and all analyses were performed using the sigma-stat software (version 3.5) Results Following DM development in rats, administration of FRN extract showed improvement in the antioxidants parameters assessed in the present study The typical signs of DM were seen (e.g increase in blood sugar, excessive urine etc.) The antioxidants of DM group showed sharp reduction in CAT activity by 4.8-fold as compared to control (Fig 1), 3-fold decreases in GSH content, 1.5-fold reduction and T-SH and 1.34-fold decreases in P-SH levels (Table 1) Treatment with FRN increases significantly the activity of CAT in the brain cortex of DM + FRN animals as compared to DM group (p < 0.05, Fig 1) This improvement accompanied by increase in the levels of thiol contents, where T-SH, GSH and P-SH contents increased in the DM + FRN group as compared to DM group (p < 0.05, Table 1) In the all above antioxidants no significant changes were seen among control and FRN Figure CAT activity in the brain cortices of control, FRN, DM DM + FRN groups Results expressed as mean ± S.D., p < 0.05 considered significant compared to control, n = in each group group, however, the contents of all thiols were less in DM + FRN group as compared to both control and FRN groups As a result of oxidative damage, proteins and albumin levels were affected in the brain cortices of DM group (decreased by 3.68 and 5.05 folds respectively, p < 0.05) when compared to control (Figs and respectively) However, administration of FRN extract brought back the levels of protein and albumin to almost the similar values of control Our results showed 3.23-fold increase in UA in DM group compared to control, meanwhile, administration of FRN to DM rats reduces this increase to levels similar to those seen in control (p < 0.05, Fig 4) To evaluate the morphological change in the brain cortices and comparing them with the biochemical findings, the histopathological observations showed irregular and large spaces around neuron cell body in the DM group with cell congestion, however, these changes were slight spaces around neuron cell body in DM + FRN group (Fig 5) No histopathological changes were seen in both control and FRN groups Discussion The increasing evidences of oxidative stress which plays a major role in the pathogenesis of DM, had lead researchers looking for natural antioxidants that might play a role in reducing the damaged caused by DM Here, we report the possible involvement of one of those natural antioxidants, FRN Figure Protein levels in the brain cortices of control, FRN, DM and DM + FRN groups Results expressed as mean ± S.D., p < 0.05 considered significant compared to control, n = in each group Please cite this article in press as: Masoud, A et al., Antioxidant effect of frankincense extract in the brain cortex of diabetic rats Journal of the Association of Arab Universities for Basic and Applied Sciences (2016), http://dx.doi.org/10.1016/j.jaubas.2016.10.003 A Masoud et al Figure Albumin levels in the brain cortices of control, FRN, DM and DM + FRN groups Results expressed as mean ± S.D., p < 0.05 considered significant compared to control, n = in each group Figure UA levels in the brain cortices of control, FRN, DM and DM + FRN groups Results expressed as mean ± S.D., p < 0.05 considered significant compared to control, n = in each group an aromatic resin from Boswellia species that used as antiinflammatory, antibacterial, antifungal and anticancer (Banno et al., 2006; Chevrier et al., 2005; Weckesser et al., 2007) and as antidiabetic induced by alloxan (Kavitha et al., 2007; Masoud et al., 2014) or streptozotocin (Azemi et al., 2012; Shehata et al., 2011) Our results showed that administration of FRN (500 mg/kg for five weeks) to the DM rats increases the antioxidant capacities in their brain cortices, hence, reduces the oxidative stress caused by DM It is well established that oxidative stress due to the generation of free radicals, glucose auto-oxidation and protein glycation plays a role in the development of DM, where, overproduction of free radical disturbs the natural balance between the production of free radicals and their antioxidant defense system (Maiese, 2015; Bonnefont-Rousselot, 2004; Desco et al., 2002; Lenzen, 2008; Muriach et al., 2014; Nowotny et al., 2015; Yan, 2014; Yang et al., 2011) This was evident from the data obtained here, where, CAT activity and thiol contents were reduced significantly in the brain cortex of DM rats Concomitantly, there were decreases in the levels of protein and albumin accompanied by increase in UA indicating disturbance in the antioxidant defense system in the brain cortices of DM rats The histopathological changes includes irregular and wide spaces around neuronal cell body Figure Histopathological changes in the brain cortices of (A) control (normal observation), (B) FRN (normal observation), (C) DM (WS, wide space around the neuronal cell bodies) and (D) DM + FRN groups (SS, slight space around the neuronal cell bodies) Please cite this article in press as: Masoud, A et al., Antioxidant effect of frankincense extract in the brain cortex of diabetic rats Journal of the Association of Arab Universities for Basic and Applied Sciences (2016), http://dx.doi.org/10.1016/j.jaubas.2016.10.003 Frankincense and diabetic brain along with congestion seen in the brain cortex of DM rats support the biochemical findings However, FRN showed a relief in the antioxidants following 500 mg/kg body weight administration for weeks We have seen that CAT activity, thiol contents, protein level, albumin level and UA level came back to almost the similar levels as seen in the control animals, suggesting the potential antioxidant effect of this natural product We reported previously that same dose of FRN helped rat’s red blood cells (RBCs) to recover from oxidative stress (induced by alloxan) by increasing the levels of antioxidant (Masoud et al., 2014) Moreover, FRN showed that it possesses antioxidant effect (Azemi et al., 2012; Mothana, 2011; Mothana et al., 2007, 2009) One of the metabolic abnormalities of DM is overproduction of superoxide radical, which is converted to H2O2 by the action of superoxide dismutase enzyme (Giacco and Brownlee, 2010) The final product, H2O2, is then processed by CAT, it is also well documented that the production of xanthine oxidase (XO) is increased, which is an enzyme plays important role in the production of ROS in DM (Romagnoli et al., 2010; Desco et al., 2002; Matsumoto et al., 2003) Here, CAT activity was reduced in DM rats and the recovery following administration of FRN could be attributed to the antioxidant action of FRN which also helped in the recovery of other non-enzymatic antioxidants Due to the presence of sulfhydryl groups (-SH) in thiols including GSH, they are one of the cellular non-enzymatic antioxidants acting as redox buffer (Meister and Anderson, 1983) and quenching ROS and other oxygen-centered free radicals (Kidd, 1997) This could explain the reductions in thiols in our study, where, oxidative stress caused by DM overwhelms the presence of natural antioxidants in brain cortices; on the other hand, FRN helped cells to recover its thiol contents Elevated UA levels might reflect the increasing activity of XO, FRN administration in DM + FRN group back up the UA level to the similar levels found in control animals The administration of FRN results in the recovery of the antioxidant of brain cortices might be due to the inhibition of the activity of XO which is responsible for the production of ROS as other drugs reported to inhibit XO (Romagnoli et al., 2010) We have reported that the changes in CAT, thiols and UA have been recovered in the RBCs of rats exposed to alloxan and treated with FRN extract (Masoud et al., 2014) In addition to these changes, brain cortices of DM rats showed histopathological changes, where, irregular and large spaces around neuron cell body along with cell congestion have been observed in DM group These observations were slight spaces around neuron cell body in DM + FRN group Our findings are consistent with different studies reported histopathological changes following DM induction (Malone et al., 2006; Edwards et al., 2010; Francis et al., 2008), however, these findings in contrast to those reported by Guven et al., who did not observe any changes in neuron following weeks of STZ-induced diabetes in rats (Guven et al., 2009) Conclusion In Conclusion, our findings in favor of using FRN to reduce the oxidative damage caused by DM Administration of FRN extract to DM rats showed significant increase in the antioxidant contents which was confirmed by histopathologi- cal studies suggesting the antioxidant beneficiary of FRN as a good candidate in the treatment of conditions that causes oxidative stress include DM with a suggestion for future study to reduce the dose less than 500 mg/kg for long period Conflict of interest No financial, personal or other conflict of interest Acknowledgements The authors are greatly acknowledged Dr Ahmad Saif Muharram, Al-Nasser Board of Trustees Chairman, for his valuable assistance References Akihisa, T., Tabata, K., Banno, N., Tokuda, H., Nishimura, R., Nakamura, Y., Kimura, Y., Yasukawa, K., Suzuki, T., 2006 Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri Biol Pharm Bull 29, 1976–1979 Azemi, M.E., Namjoyan, F., Khodayar, M.J., Ahmadpour, F., Darvish Padok, A., Panahi, M., 2012 The antioxidant capacity and anti-diabetic effect of Boswellia serrata triana and planch aqueous extract in fertile female diabetic rats and the possible effects on reproduction and histological changes in the liver and kidneys Jundishapur J Nat Pharm Prod 7, 168–175 Banno, N., Akihisa, T., Yasukawa, K., Tokuda, H., Tabata, K., Nakamura, Y., Nishimura, R., Kimura, Y., Suzuki, T., 2006 Antiinflammatory activities of the triterpene acids from the resin of Boswellia carteri J Ethnopharmacol 107, 249–253 Biessels, G.J., Staekenborg, S., Brunner, E., Brayne, C., Scheltens, P., 2006 Risk of dementia in diabetes mellitus: a systematic review Lancet Neurol 5, 64–74 Bonnefont-Rousselot, D., 2004 The role of antioxidant micronutrients in the prevention of diabetic complications Treat Endocrinol 3, 41–52 Brownlee, M., 2005 The pathobiology of diabetic complications: a unifying mechanism Diabetes 54, 1615–1625 Chevrier, M.R., Ryan, A.E., Lee, D.Y., Zhongze, M., Wu-Yan, Z., Via, C.S., 2005 Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro Clin Diagn Lab Immunol 12, 575–580 Desco, M.C., Asensi, M., Marquez, R., Martinez-Valls, J., Vento, M., Pallardo, F.V., Sastre, J., Vina, J., 2002 Xanthine oxidase is involved in free radical production in type diabetes: protection by allopurinol Diabetes 51, 1118–1124 Devi, P.R., Adilaxmamma, K., Rao, G.S., Srilatha, Ch., Raj, M.A., 2012 Safety evaluation of alcoholic extract of Boswellia ovalifoliolata Stem-bark in Rats Toxicol Int 19, 115–120 Edwards, J.L., Quattrini, A., Lentz, S.I., Figueroa-Romero, C., Cerri, F., Backus, C., Hong, Y., Feldman, E.L., 2010 Diabetes regulates mitochondrial biogenesis and fission in mouse neurons Diabetologia 53, 160–169 Ellman, G.L., 1959 Tissue sulfhydryl groups Arch Biochem Biophys 82, 70–77 Exalto, L.G., Whitmer, R.A., Kappele, L.J., Biessels, G.J., 2012 An update on type diabetes, vascular dementia and Alzheimer’s disease Exp Gerontol 47, 858–864 Francis, G.J., Martinez, J.A., Liu, W.Q., Xu, K., Ayer, A., Fine, J., Tuor, U.I., Glazner, G., Hanson, L.R., Frey 2nd, W.H., Toth, C., 2008 Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy Brain 131, 3311–3334 Please cite this article in press as: Masoud, A et al., Antioxidant effect of frankincense extract in the brain cortex of diabetic rats Journal of the Association of Arab Universities for Basic and Applied Sciences (2016), http://dx.doi.org/10.1016/j.jaubas.2016.10.003 Giacco, F., Brownlee, M., 2010 Oxidative stress and diabetic complications Circ Res 107, 1058–1070 Gorelick, P.B., Scuteri, A., Black, S.E., Decarli, C., Greenberg, S.M., Iadecola, C., Launer, L.J., Laurent, S., Lopez, O.L., Nyenhuis, D., Petersen, R.C., Schneider, J.A., Tzourio, C., Arnett, D.K., Bennett, D.A., Chui, H.C., Higashida, R.T., Lindquist, R., Nilsson, P.M., Roman, G.C., Sellke, F.W., Seshadri, S., 2011 Council on Epidemiology American Heart Association Stroke Council, Council on Cardiovascular Nursing Council on Cardiovascular Radiology Prevention, Intervention, Surgery Council on Cardiovascular, and Anesthesia Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association Stroke 42, 2672–2713 Gupta, I., Gupta, V., Parihar, A., Gupta, S., Ludtke, R., Safayhi, H., Ammon, H.P., 1998 Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebocontrolled, 6-week clinical study Eur J Med Res 3, 511–514 Guven, A., Yavuz, O., Cam, M., Comunoglu, C., Sevi’nc, O., 2009 Central nervous system complications of diabetes in streptozotocininduced diabetic rats: a histopathological and immunohistochemical examination Int J Neurosci 119, 1155–1169 Kavitha, J.V., Rosario, J.F., Chandran, J., Anbu, P., Bakkiyanathan, 2007 Hypoglycemic and other related effects of Boswellia glabra in alloxan-induced diabetic rats Indian J Physiol Pharmacol 51, 29– 39 Kidd, P.M., 1997 Glutathione: systemic protectant against oxidative and free radical damage Alternat Med Rev 2, 155–176 King, A.J., 2012 The use of animal models in diabetes research Br J Pharmacol 166, 877–894 Lenzen, S., 2008 The mechanisms of alloxan- and streptozotocininduced diabetes Diabetologia 51, 216–226 Luck, H 1971 Catalase In: Bergmeyer, H.U (Ed.) Academic Press, New York Maiese, K., 2015 New insights for oxidative stress and diabetes mellitus Oxid Med Cell Longev 2015, 875961 Malone, J.I., Hanna, S.K., Saporta, S., 2006 Hyperglycemic brain injury in the rat Brain Res 1076, 9–15 Masoud, A., Al-Ghazali, M., Al-Futini, F., Alzagruri, S., Al-Ansi, E., Salama, A., Al-Selwi, H., 2014 Ameliorating effect of frankincense on red blood cells of Alloxan induced-diabetes in rat Int J Pharmaceut Sci Invent 3, 23–27 Matsumoto, S., Koshiishi, I., Inoguchi, T., Nawata, H., Utsumi, H., 2003 Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabeticmice Free Radic Res 37, 767– 772 A Masoud et al Meister, A., Anderson, M.E., 1983 Glutathione Annu Rev Biochem 52, 711–760 Mothana, R.A., 2011 Anti-inflammatory, antinociceptive and antioxidant activities of the endemic Soqotraen Boswellia elongata Balf f and Jatropha unicostata Balf f in different experimental models Food Chem Toxicol 49, 2594–2599 Mothana, R.A., Grunert, R., Lindequist, U., Bednarski, P.J., 2007 Study of the anticancer potential of Yemeni plants used in folk medicine Pharmazie 62, 305–307 Mothana, R.A., Lindequist, U., Gruenert, R., Bednarski, P.J., 2009 Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra BMC Complement Altern Med 9, Muriach, M., Flores-Bellver, M., Romero, F.J., Barcia, J.M., 2014 Diabetes and the brain: oxidative stress, inflammation, and autophagy Oxid Med Cell Longev 2014, 102158 Nowotny, K., Jung, T., Hohn, A., Weber, D., Grune, T., 2015 Advanced glycation end products and oxidative stress in type diabetes mellitus Biomolecules 5, 194–222 Romagnoli, M., Gomez-Cabrera, M., Perrelli, M., Biasi, F., Pallardo´, F., Sastre, J., Poli, J., Vin˜a, J., 2010 Xanthine oxidase-induced oxidative stress causes activation of NF-jB and inflammation in the liver of type I diabetic rats Free Radical Biol Med 49, 171– 177 Sedlak, J., Lindsay, R.H., 1968 Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent Anal Biochem 25, 192–205 Shehata, A.M., Quintanilla-Fend, L., Bettio, S., Singh, C.B., Ammon, H.P., 2011 Prevention of multiple low-dose streptozotocin (MLDSTZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE) Phytomedicine 18, 1037–1044 Wasserman, D.H., 2009 Four grams of glucose Am J Physiol Endocrinol Metab 296, E11–E21 Weckesser, S., Engel, K., Simon-Haarhaus, B., Wittmer, A., Pelz, K., Schempp, C.M., 2007 Screening of plant extracts for antimicrobial activity against bacteria and yeasts with dermatological relevance Phytomedicine 14, 508–516 Whiting, D.R., Guariguata, L., Weil, C., Shaw, J., 2011 IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 Diabetes Res Clin Pract 94, 311–321 Yan, L.J., 2014 Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress J Diabetes Res 2014, 137919 Yang, H., Jin, X., Kei Lam, C.W., Yan, S.K., 2011 Oxidative stress and diabetes mellitus Clin Chem Lab Med 49, 1773–1782 Please cite this article in press as: Masoud, A et al., Antioxidant effect of frankincense extract in the brain cortex of diabetic rats Journal of the Association of Arab Universities for Basic and Applied Sciences (2016), http://dx.doi.org/10.1016/j.jaubas.2016.10.003 ... http://dx.doi.org/10.1016/j.jaubas.2016.10.003 Frankincense and diabetic brain along with congestion seen in the brain cortex of DM rats support the biochemical findings However, FRN showed a relief in the antioxidants following 500... around the neuronal cell bodies) Please cite this article in press as: Masoud, A et al., Antioxidant effect of frankincense extract in the brain cortex of diabetic rats Journal of the Association of. .. changes in murine type I diabetic encephalopathy Brain 131, 3311–3334 Please cite this article in press as: Masoud, A et al., Antioxidant effect of frankincense extract in the brain cortex of diabetic